Bolt Biotherapeutics
BOLT
BOLT
36 hedge funds and large institutions have $17M invested in Bolt Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
49% less capital invested
Capital invested by funds: $33.6M → $17M (-$16.6M)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$295K | |
| 2 | +$136K | |
| 3 | +$84.4K | |
| 4 |
Jane Street
New York
|
+$31.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$27.5K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$253K | |
| 3 | -$181K | |
| 4 |
Squarepoint
New York
|
-$109K |
| 5 |
Millennium Management
New York
|
-$64.3K |